Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Eva Perez-Pampin

Profesora Asociada

Universidade de Santiago de Compostela Facultade de Medicina e Odontoloxía

Spain

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

70%

Internal Medicine

30%

Arthritis

60%

Rheumatology

50%

Inflammatory Biology

40%

Autoinflammatory Disease

40%

Biologic Therapy

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles12

Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry

Article Link

Year:

2024

Clinical features and immune mechanisms directly linked to the altered liver function in patients with rheumatoid arthritis

Article Link

Year:

2023

Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression

Article Link

Year:

2023

Antibodies against 4 Atypical Post-Translational Protein Modifications in Patients with Rheumatoid Arthritis

Article Link

Year:

2022

ROCK inhibition with Y-27632 reduces joint inflammation and damage in serum-induced arthritis model and decreases in vitro osteoclastogenesis in patients with early arthritis

Article Link

Year:

2022

Validation of screening criteria for spondyloarthritis in patients with inflammatory bowel disease in routine clinical practice

Article Link

Year:

2022

Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large Cohorts.

Article Link

Year:

2021

HLA-B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti-Carbamylated Protein Antibody-Positive/Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid Arthritis.

Article Link

Year:

2021

Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients

Article Link

Year:

2021

A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis

Article Link

Year:

2020

NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: Results from the REPAIR consortium

Article Link

Year:

2020

Association of serum anti-centromere protein F antibodies with clinical response to infliximab in patients with rheumatoid arthritis: A prospective study.

Article Link

Year:

2020

Collaborators12

Jose Cordoba-Chacon

Assistant Professor

University of Chicago

UNITED STATES

Fernando Leiva-Cepas

Profesor Contratado Doctor vinculado de Anatomía Patológica

Universidad de Córdoba

SPAIN

JUAN SAINZ

Assistant Professor

Universidad de Granada

SPAIN

Javier Rodriguez Garcia

Profesor Asociado

Universidade de Santiago de Compostela

SPAIN

CHARY LOPEZ-PEDRERA

Head of Research

SPAIN

Katarzyna Bogunia-Kubik

Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences

POLAND

Manuel D. Gahete

Head

SPAIN

Naomi Diz Rosales

Professor (Pre-doctoral contract)

Universidade da Coruña Facultade de Informática

SPAIN

Jose Manuel Sánchez Maldonado

Universidad de Granada

SPAIN

Rachel Knevel

UNITED KINGDOM

Sara Manrique-Arija

Associate Lecturer

Universidad de Málaga Facultad de Medicina

SPAIN

Lucía Otero Varela

Profesora

Universidad CEU San Pablo

SPAIN

How do I reach out?

Meet Kite AI